Literature DB >> 6814729

Osteopenia with decreased bone formation in beagles with malabsorption syndrome.

B N Kunkle, R W Norrdin, R K Brooks, R W Thomassen.   

Abstract

Morphometric and bone density studies were performed on bones from 10 healthy adult dogs and 9 dogs that had exhibited signs of intestinal malabsorption for variable periods of time. The dogs with malabsorption syndrome had a marked decrease in the amount of trabecular bone in lumbar vertebrae (P less than 0.001). Evaluation of undecalcified rib cross sections revealed these dogs had a decrease in trabecular thickness (P less than 0.01) and cortical area (P less than 0.01). There was a decrease in the proportion of the trabecular surface covered with osteoblasts (P less than 0.01) and an increase in resting resorption surface (P less than 0.01) and trabecular specific surface (P less than 0.01). Three of the dogs with malabsorption syndrome and all control dogs were labeled with oxytetracycline prior to sacrifice. The dogs with malabsorption syndrome had a decreased number or complete absence of labeled bone formation sites when compared to controls. No difference was found in bone mineral density in the malabsorption cases as a group, although 1 of the dogs that had an increase in percent osteoid volume and percent osteoid-covered surface had lower ash/ml in trabecular bone samples from lumbar vertebrae. Parathyroid gland weights were available for 6 of the 9 dogs, and these were not significantly different from controls. The findings indicate that decreased bone formation, probably due to the poor nutritional status associated with malabsorption, was an important factor in the development of osteopenia.

Entities:  

Mesh:

Year:  1982        PMID: 6814729     DOI: 10.1007/bf02411274

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  29 in total

1.  A morphologic and histochemical analysis of the human jejunal epithelium in nontropical sprue.

Authors:  H A PADYKULA; E W STRAUSS; A J LADMAN; F H GARDNER
Journal:  Gastroenterology       Date:  1961-06       Impact factor: 22.682

2.  Absorption and elimination of 15-N after administration of isotopically labelled yeast protein and yeast protein hydrolysate to adult patients with coeliac disease. 1. Rate of absorption of 15-N yeast protein and yeast protein hydrolysate.

Authors:  C W CRANE; A NEUBERGER
Journal:  Br Med J       Date:  1960-09-17

3.  Experimental production of steatitis yellow fat disease) in kittens fed a commercial canned cat food and prevention of the condition by vitamin E.

Authors:  D R CORDY
Journal:  Cornell Vet       Date:  1954-07

4.  Bone metabolism and composition in the protein-deprived rat.

Authors:  D Le Roith; B L Pimstone
Journal:  Clin Sci       Date:  1973-04       Impact factor: 6.124

5.  Quantitative relations between osteoblasts and osteoid in primary hyperparathyroidism, intestinal malabsorption ad renal osteodystrophy.

Authors:  A J Olah
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973-02-19

6.  Malabsorption syndrome in the dog: a study of thirty-eight cases.

Authors:  F W Hill
Journal:  J Small Anim Pract       Date:  1972-10       Impact factor: 1.522

7.  Effects of intravenous vitamin D on bone and phosphate metabolism in osteomalacia.

Authors:  P Bordier; D Hioco; M Rouquier; G W Hepner; G R Thompson
Journal:  Calcif Tissue Res       Date:  1969-08-11

8.  Histological observations on bone in intestinal malabsorption and vitamin D deficiency.

Authors:  J A Fischer; U Binswanger; R K Schenk; W Merz
Journal:  Horm Metab Res       Date:  1970-03       Impact factor: 2.936

9.  Metabolic bone disease after intestinal bypass for treatment of obesity.

Authors:  A M Parfitt; M J Miller; B Frame; A R Villanueva; D S Rao; I Oliver; D L Thomson
Journal:  Ann Intern Med       Date:  1978-08       Impact factor: 25.391

10.  The effects of small-bowel resection or bypass on the rat skeleton.

Authors:  D J Simmons; G Hyland; P A Lesker; M Cohen; T Stein; L Wise
Journal:  Surgery       Date:  1975-10       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.